The TNI-EMCDDA Expert Seminar on Threshold Quantities reflected on the advantages and disadvantages of threshold quantities as a policy and legislative tool and it was hoped that this seminar would provide a springboard to inform current debate and to assist the elaboration of evidence-based drug law reform proposals now and in the future.
Anti-drug public service announcements (PSAs) have become a cornerstone of drug policy in the USA. However, studies of the effectiveness of these interventions have not been subjected to a systematic evaluation.
This briefing examines the drug-related problems and evaluates the policy responses in Nagaland and Manipur, two sparsely populated states which have the highest prevalence of injecting drug users in India.
This briefing provides an overview of the current discussion around threshold quantities and explores the mechanism of threshold quantities including their benefits and drawbacks as a policy and legal tool.
While overall growth in numbers of new HIV infections has slowed in most regions of the world, infections linked to injection drug use continue to grow. This trend has been most pronounced in Eastern Europe and Central Asia; however, new infections related to injection drug use also appear to be growing in East Africa.
This is the first edition of the International Journal on Human rights and Drug Policy, the only international peer reviewed law journal focusing exclusively on human rights and drug policy.
This briefing paper provides an overview of issues related to kratom legislation and policy in Thailand as well as a set of conclusions and recommendations to contribute to a reassessment of the current ban on kratom in Thailand and the region.
The International Journal on Human Rights and Drug Policy seeks to expand the current body of legal research and analysis on drug policy issues as they intersect with international human rights law, international humanitarian law and international criminal law.
The South East European Drug Policy Network held its third meeting in Thessaloniki, Greece in March 2011, during which participants shared knowledge and experiences from across the region, and identify common problems and key priorities for drug policy advocacy.
With over two years in office, the Obama Administration has had time to begin to make its mark on the government's domestic and international drug policies. This briefing paper analyses the modest changes that have taken place to date.
This report aims to provide the reader with a summary of what happened at 54th Session of the Commission on Narcotic Drugs, including at various satellite events, and offers some analysis of the key discussions and debates.